POS0046 PRELIMINARY RESULTS OF AN OPEN-LABEL, MULTICENTRE, PHASE 1/2 STUDY TO ASSESS SAFETY, EFFICACY AND CELLULAR KINETICS OF YTB323 (RAPCABTAGENE AUTOLEUCEL), A RAPIDLY MANUFACTURED CAR T-CELL THERAPY TARGETING CD19 ON B CELLS, FOR SEVERE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Cortés-Hernández J., Barba P., Alvaro-Gracia J.M., Kwon M., Weinmann-Menke J.,Wagner-Drouet E., Fischer O., Kovacs B.,Chaperon F., Pearson D., Kirsilä T., Sean Lee C.Y., Drakeford C.,Gergely P., Cavalli G., Shisha T.

Annals of the Rheumatic Diseases（2024）

引用 0|浏览0

关键词

Clinical Trial,Safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要